When a patient who is started on ACE-inhibitor therapy is followed, an important laboratory parameter to monitor is the serum:
1. troponin level.
2. neutrophil count.
3. erythrocyte sedimentation rate.
4. uric acid.
Question 2
The nurse counsels a patient beginning therapy on an angiotensin IIreceptor blocker (valsartan). A side effect that should be included in the drug education is:
1. cough.
2. heart failure.
3. dehydration.
4. angioedema.